A collection of spirooxindole-cyclopentene-isoxazole hybrids bearing multiple chiral centers and varied groups as potential MDM2-p53 inhibitors were designed and synthesized via a rarely reported organocatalytic 1,6-cycloaddition with exclusive α-regioselectivity. In...